Pregabalin for Pain Reduction in Critical Limb Ischemia - A Double Blind, Randomized Controlled Study.

Trial Profile

Pregabalin for Pain Reduction in Critical Limb Ischemia - A Double Blind, Randomized Controlled Study.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 21 Jun 2018

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Ischaemic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jun 2018 Status changed from recruiting to discontinued.
    • 07 May 2015 Planned End Date changed from 1 Jul 2009 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
    • 07 May 2015 Planned primary completion date changed from 1 Jun 2009 to 1 May 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top